"**Cluster Summary**\n\n### Cluster 0\n- **Number of samples:** 122\n- **Average feature values:**\n  - age: 55.459\n  - trestbps: 130.450\n  - chol: 0\n  - thalch: 121.238\n  - oldpeak: 0.661\n  - ca: 0.0656\n- **Distribution of categorical features:**\n  - sex:\n    - Female: 10/122 (8.2%)\n    - Male: 112/122 (91.8%)\n  - cp:\n    - asymptomatic: 98/122 (80.3%)\n    - atypical angina: 4/122 (3.3%)\n    - non-anginal: 16/122 (13.1%)\n    - typical angina: 4/122 (3.3%)\n  - fbs:\n    - False: 117/122 (95.9%)\n    - True: 5/122 (4.1%)\n  - restecg:\n    - normal: 85/122 (69.7%)\n    - st-t abnormality: 30/122 (24.6%)\n    - lv hypertrophy: 7/122 (5.7%)\n  - exang:\n    - False: 68/122 (55.7%)\n    - True: 54/122 (44.3%)\n  - slope:\n    - upsloping: 32/122 (26.2%)\n    - flat: 78/122 (63.9%)\n    - downsloping: 12/122 (9.8%)\n  - thal:\n    - normal: 70/122 (57.4%)\n    - reversable defect: 42/122 (34.4%)\n    - fixed defect: 10/122 (8.2%)\n- **Heart Disease Stage distribution:**\n  - Stage 0: 0/122 (0%)\n  - Stage 1: 82/122 (67.2%)\n  - Stage 2: 25/122 (20.5%)\n  - Stage 3: 10/122 (8.2%)\n  - Stage 4: 5/122 (4.1%)\n\n### Cluster 1\n- **Number of samples:** 256\n- **Average feature values:**\n  - age: 57.109\n  - trestbps: 135.422\n  - chol: 205.852\n  - thalch: 124.156\n  - oldpeak: 1.294\n  - ca: 0\n  - Heart Disease Stage: 1.457\n- **Distribution of categorical features:**\n  - sex:\n    - Female: 7/256 (2.7%)\n    - Male: 249/256 (97.3%)\n  - cp:\n    - asymptomatic: 202/256 (78.9%)\n    - atypical angina: 9/256 (3.5%)\n    - non-anginal: 38/256 (14.8%)\n    - typical angina: 7/256 (2.7%)\n  - fbs:\n    - False: 178/256 (69.5%)\n    - True: 78/256 (30.5%)\n  - restecg:\n    - normal: 129/256 (50.4%)\n    - st-t abnormality: 105/256 (41%)\n    - lv hypertrophy: 22/256 (8.6%)\n  - exang:\n    - False: 91/256 (35.6%)\n    - True: 165/256 (64.4%)\n  - slope:\n    - upsloping: 13/256 (5.1%)\n    - flat: 214/256 (83.6%)\n    - downsloping: 29/256 (11.3%)\n  - thal:\n    - normal: 223/256 (87.1%)\n    - reversable defect: 23/256 (9%)\n    - fixed defect: 10/256 (3.9%)\n- **Heart Disease Stage distribution:**\n  - Stage 0: 0/256 (0%)\n  - Stage 1: 122/256 (47.7%)\n  - Stage 2: 56/256 (21.9%)\n  - Stage 3: 52/256 (20.3%)\n  - Stage 4: 26/256 (10.2%)\n\n### Cluster 2\n- **Number of samples:** 160\n- **Average feature values:**\n  - age: 51.431\n  - trestbps: 129.994\n  - chol: 250.337\n  - thalch: 148.831\n  - oldpeak: 0.444\n  - ca: 0.156\n  - Heart Disease Stage: 0.1125\n- **Distribution of categorical features:**\n  - sex:\n    - Female: 160/160 (100%)\n    - Male: 0/160 (0%)\n  - cp:\n    - asymptomatic: 39/160 (24.4%)\n    - atypical angina: 61/160 (38.1%)\n    - non-anginal: 51/160 (31.9%)\n    - typical angina: 9/160 (5.6%)\n  - fbs:\n    - False: 148/160 (92.5%)\n    - True: 12/160 (7.5%)\n  - restecg:\n    - normal: 101/160 (63.1%)\n    - st-t abnormality: 22/160 (13.8%)\n    - lv hypertrophy: 37/160 (23.1%)\n  - exang:\n    - False: 136/160 (85%)\n    - True: 24/160 (15%)\n  - slope:\n    - upsloping: 54/160 (33.8%)\n    - flat: 104/160 (65%)\n    - downsloping: 2/160 (1.3%)\n  - thal:\n    - normal: 152/160 (95%)\n    - reversable defect: 6/160 (3.8%)\n    - fixed defect: 2/160 (1.3%)\n- **Heart Disease Stage distribution:**\n  - Stage 0: 8/160 (5%)\n  - Stage 1: 40/160 (25%)\n  - Stage 2: 52/160 (32.5%)\n  - Stage 3: 28/160 (17.5%)\n  - Stage 4: 32/160 (20%)\n\n### Cluster 3\n- **Number of samples:** 227\n- **Average feature values:**\n  - age: 47.854\n  - trestbps: 129.194\n  - chol: 233.626\n  - thalch: 151.837\n  - oldpeak: 0.279\n  - ca: 0.0308\n  - Heart Disease Stage: 0.1674\n- **Distribution of categorical features:**\n  - sex:\n    - Female: 0/227 (0%)\n    - Male: 227/227 (100%)\n  - cp:\n    - asymptomatic: 49/227 (21.6%)\n    - atypical angina: 94/227 (41.5%)\n    - non-anginal: 76/227 (33.5%)\n    - typical angina: 8/227 (3.5%)\n  - fbs:\n    - False: 210/227 (92.5%)\n    - True: 17/227 (7.5%)\n  - restecg:\n    - normal: 179/227 (78.8%)\n    - st-t abnormality: 20/227 (8.8%)\n    - lv hypertrophy: 28/227 (12.3%)\n  - exang:\n    - False: 217/227 (95.6%)\n    - True: 10/227 (4.4%)\n  - slope:\n    - upsloping: 59/227 (26%)\n    - flat: 163/227 (71.9%)\n    - downsloping: 5/227 (2.2%)\n  - thal:\n    - normal: 208/227 (91.6%)\n    - reversable defect: 11/227 (4.8%)\n    - fixed defect: 8/227 (3.5%)\n- **Heart Disease Stage distribution:**\n  - Stage 0: 20/227 (8.8%)\n  - Stage 1: 81/227 (35.7%)\n  - Stage 2: 50/227 (22.1%)\n  - Stage 3: 44/227 (19.4%)\n  - Stage 4: 32/227 (14%)\n\n### Cluster 4\n- **Number of samples:** 157\n- **Average feature values:**\n  - age: 56.4645\n  - trestbps: 133.7226\n  - chol: 246.0065\n  - thalch: 140.7871\n  - oldpeak: 1.5394\n  - ca: 1.0903\n  - Heart Disease Stage: 1.7097\n- **Distribution of categorical features:**\n  - sex:\n    - Female: 17/157 (10.8%)\n    - Male: 140/157 (89.2%)\n  - cp:\n    - asymptomatic: 108/157 (68.8%)\n    - atypical angina: 6/157 (3.8%)\n    - non-anginal: 23/157 (14.6%)\n    - typical angina: 20/157 (12.8%)\n  - fbs:\n    - False: 129/157 (82.2%)\n    - True: 28/157 (17.8%)\n  - restecg:\n    - normal: 59/157 (37.6%)\n    - st-t abnormality: 2/157 (1.3%)\n    - lv hypertrophy: 44/157 (28.0%)\n  - exang:\n    - False: 71/157 (45.2%)\n    - True: 86/157 (54.8%)\n  - slope:\n    - upsloping: 45/157 (28.6%)\n    - flat: 95/157 (60.5%)\n    - downsloping: 17/157 (10.8%)\n  - thal:\n    - normal: 29/157 (18.5%)\n    - reversable defect: 109/157 (69.4%)\n    - fixed defect: 19/157 (12.1%)\n- **Heart Disease Stage distribution:**\n  - Stage 0: 4/157 (2.6%)\n  - Stage 1: 71/157 (45.2%)\n  - Stage 2: 28/157 (17.8%)\n  - Stage 3: 32/157 (20.4%)\n  - Stage 4: 22/157 (14%)"